Some recurrent fusions appear to be almost exclusively clonal (CCDC6-RET, BRAF-KIAA1549, and TMPRSS2-ERG), suggesting that gain-of-function SVs occur early during tumor development. This evidence concerns the gene KIAA1549 and neoplasm.